Implementing Strategic Development and Innovating Disruptive Business Models for Transformative Cell and Gene Therapies


  • Michael C. Rice , Principal, Cello Health BioConsulting


  • Sam Hall , Apple Tree Partners
  • RA Session , Chief Business Officer, BridgeBio Gene Therapy
  • Jean Philippe Combal , Co Founder & CEO, Vivet Therapeutics
  • Chip Baird, Chief Financial Officer, bluebird bio